Avidity Biosciences (RNA) Non Operating Investment Income (2020 - 2023)
Historic Non Operating Investment Income for Avidity Biosciences (RNA) over the last 4 years, with Q2 2023 value amounting to -$1.1 million.
- Avidity Biosciences' Non Operating Investment Income fell 1843.75% to -$1.1 million in Q2 2023 from the same period last year, while for Jun 2023 it was $320000.0, marking a year-over-year increase of 11071.67%. This contributed to the annual value of -$2.5 million for FY2022, which is 127967.03% down from last year.
- According to the latest figures from Q2 2023, Avidity Biosciences' Non Operating Investment Income is -$1.1 million, which was down 1843.75% from $1.2 million recorded in Q1 2023.
- In the past 5 years, Avidity Biosciences' Non Operating Investment Income registered a high of $1.2 million during Q1 2023, and its lowest value of -$1.8 million during Q1 2022.
- For the 4-year period, Avidity Biosciences' Non Operating Investment Income averaged around -$242363.6, with its median value being -$5000.0 (2020).
- Examining YoY changes over the last 5 years, Avidity Biosciences' Non Operating Investment Income showed a top increase of 51129.03% in 2022 and a maximum decrease of 9205000.0% in 2022.
- Avidity Biosciences' Non Operating Investment Income (Quarter) stood at -$5000.0 in 2020, then crashed by 3620.0% to -$186000.0 in 2021, then skyrocketed by 511.29% to $765000.0 in 2022, then crashed by 248.63% to -$1.1 million in 2023.
- Its Non Operating Investment Income stands at -$1.1 million for Q2 2023, versus $1.2 million for Q1 2023 and $765000.0 for Q4 2022.